Skip to content

Making Sense of OSHA’s Controversial Drug Testing Position

Making Sense of OSHA’s Controversial Drug Testing Position

AGCA Webinar: Making Sense of OSHA’s Controversial Drug Testing Position in the Context of Injury and illness Reporting

AGCA_bugThe AGC Oregon-Columbia Chapter will be hosting this WebEd session at the AGC offices in Wilsonville.

Date: 10/31/2016, 11 am–12 pm
Location: 9450 SW Commerce Cor Ste 200, Wilsonville, OR, 97070

On December 1, 2016, OSHA will begin enforcing an electronic injury and illness reporting rule that may prohibit or restrict your company’s post-incident drug testing program and safety incentive programs. Under this new rule, OSHA may cite contractors for such programs in the context of their possibly discouraging employees from reporting injuries and illnesses. Learning Objective: During this webinar, safety and health law attorney Bradford Hammock, AGC’s senior director of safety Kevin Cannon and regulatory counsel Jimmy Christianson will:

  • Discuss if employer’s current injury and illness reporting policies are compliant with the new “anti-retaliatory” provisions.
  • Identify areas (e.g. safety incentive programs, mandatory post-incident drug testing, and safety disciplinary policies) that employers may need to focus on to ensure compliance with the new requirements.
  • Discuss the new electronic reporting requirements and effective dates.

Two Options to Attend


Colette Evers, 503-685-8328.

Share This Resource

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Related Articles

How to help construction employees be resilient Employees who feel safe and are mentally well also perform better on the job and are less likely...
Miller Nash LLP is pleased to announce the date of our virtual half-day 2021 Employment Law Seminar: Wednesday, December 8 from 8:30 a.m. – 12:30 p.m. PT. Our...
Did you know as a member you have access to recordings of past events? Our Member Media Library is a hub for recordings, PowerPoints, and...